[1]Kalluri R. The biology and function of exosomes in cancer\[J\]. J Clin Invest, 2016, 126(4): 1208-1215.
[2]Marco T, Wan L, Lory S, et al. Exosomederived microRNAs in cancer metabolism: possible implications in cancer diagnostics and therapy\[J\]. Exp Mol Med, 2017, 49 (1): e285.
[3]Enderle D, Spiel A, Coticchia C, et al. Characterization of RNA from exosomes and other extracellular vesicles isolated by a novel spin columnbased method\[J\]. PLoS One, 2015, 10: e0136133.
[4]Wang XF, Luo GT, Zhang KD, et al. Hypoxic tumorderived exosomal miR301a mediates M2 macrophage polarization via PTEN/PI3Kγ to promote pancreatic cancer metastasis\[J\]. Cancer Res, 2018, 78(16): 4586-4598.
[5]Chiba M, Watanabe N, Watanabe M, et al. Exosomes derived from SW480 colorectal cancer cells promote cell migration in HepG2 hepatocellular cancer cells via the mitogenactivated protein kinase pathway\[J\]. Int J Oncol, 2016, 48(1):305-312.
[6]Kamerkar S, Lebleu VS, Sugimoto H, et al. Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer\[J\]. Nature, 2017, 546 (7659): 498-503.
[7]Gutschner T, Diederichs S. The hallmarks of cancer: a long noncoding RNA point of view\[J\]. RNA Biol, 2012, 9(6): 703-719.
[8]Kung JTY, Colognori D, Lee JT. Long noncoding RNAs: past, present, and future\[J\]. Genetics, 2013, 193(3): 651-669.
[9]Rinn JL, Chang HY. Genome regulation by long noncoding RNAs\[J\]. Annu Rev Biochem, 2012, 81(1): 145-166.
[10]Feng S, Yao J, Chen Y, et al. Expression and functional role of reprogrammingrelated long noncoding RNA (lincRNAROR) in glioma\[J\]. J Mol Neurosci, 2015, 56(3): 623-630.
[11]Gong PH, Qiao FC, Wu HZ, et al. LncRNA UCA1 promotes tumor metastasis by inducing miR203/ZEB2 axis in gastric cancer\[J\]. Cell Death Dis, 2018, 9 (12): 1158.
[12]Chen W, Wang HZ, Liu YW, et al. LincRoR promotes proliferation, migration, and invasion via the Hippo/YAP pathway in pancreatic cancer cells\[J\]. J Cell Biochem, 2020, 121(1): 632-641.
[13]Zhou JJ, Cheng D, He XY, et al. Knockdown of long noncoding RNA HOTAIR sensitizes hepatocellular carcinoma cell to cisplatin by suppressing the STAT3/ABCB1 signaling pathway\[J\]. Oncol Lett, 2017, 14(6): 7986-7992.
[14]Huang X, Yuan T, Tschannen M, et al. Characterization of human plasmaderived exosomal RNAs by deep sequencing\[J\]. BMC Genomics, 2013, 14: 319.
[15]Gezer U, zgür E, Cetinkaya M, et al. Long noncoding RNAs with low expression levels in cells are enriched in secreted exosomes\[J\].Cell Biol Int, 2014, 38 (9): 1076-1079.
[16]Huang L, Wang Y, Chen J, et al. Long noncoding RNA PCAT1, a novel serumbased biomarker, enhances cell growth by sponging miR326 in esophageal squamous cell carcinoma\[J\]. Cell Death Dis, 2019, 10 (7): 513.
[17]Li W, Zhang L, Guo B, et al. Exosomal FMR1AS1 facilitates maintaining cancer stemlike cell dynamic equilibrium via TLR7/NFκB/cMyc signaling in female esophageal carcinoma\[J\]. Mol Cancer, 2019, 18(1): 22.
[18]Min K, Meiping R, Yan L, et al. Exosomemediated transfer of lncRNA PART1 induces gefitinib resistance in esophageal squamous cell carcinoma via functioning as a competing endogenous RNA\[J\]. J Exp Clin Cancer Res, 2018, 37(1): 171.
[19]Pan L, Liang W, Fu M, et al. Exosomesmediated transfer of long noncoding RNA ZFAS1 promotes gastric cancer progression\[J\].J Cancer Res Clin Oncol, 2017, 143(6): 991-1004.
[20]Kogure T, Yan IK, Lin WL, et al.Extracellular vesiclemediated transfer of a novel long noncoding RNA TUC339: a mechanism of intercellular signaling in human hepatocellular cancer\[J\]. Genes Cancer, 2013, 4(7-8): 261-272.
[21]Conigliaro A, Costa V, Lo Dico A, et al. CD90+ liver cancer cells modulate endothelial cell phenotype through the release of exosomes containing H19 lncRNA\[J\]. Mol Cancer, 2015, 14: 155.
[22]Takahashi K, Yan IK, Wood J, et al. Involvement of extracellular vesicle long noncoding RNA (lincVLDLR) in tumor cell responses to chemotherapy\[J\]. Mol Cancer Res, 2014, 12(10): 1377-1387.
[23]Takahashi K, Yan IK, Kogure K, et al. Extracellular vesiclemediated transfer of long noncoding RNA ROR modulates chemosensitivity in human hepatocellular cancer\[J\]. FEBS Open Bio, 2014, 9(4): 458-467.
[24]Wang X, Li H, Lu X, et al. Melittininduced long noncoding RNA NONHSAT105177 inhibits proliferation and migration of pancreatic ductal adenocarcinoma\[J\].Cell Death Dis, 2018, 9(10): 940.
[25]Takahashi K, Ota Y, Suzuki Y, et al. Circulating extracellular vesicleencapsulated HULC is a potential biomarker for human pancreatic cancer\[J\]. Cancer Sci, 2020, 111(1):98-111.
[26]Li Z, Jiang P, Li J, et al. Tumorderived exosomal lncSox2ot promotes EMT and stemnessby acting as a ceRNA in pancreatic ductal adenocarcinoma\[J\]. Oncogene, 2018, 37(28): 3822-3838.
[27]Chen JH, Wang SW, Jia SN, et al. Integrated analysis of long noncoding RNA and mRNA expression profile in pancreatic cancer derived exosomes treated dendritic cells by microarray analysis\[J\]. J Cancer, 2018, 9(1): 21-31.
[28]Gao T, Liu X, He B, et al. Exosomal lncRNA 91H is associated with poor development in colorectal cancer by modifying HNRNPK expression\[J\]. Cancer Cell Int, 2018, 18:11.
[29]Ren J, Ding L, Zhang D,et al. Carcinomaassociated fbroblasts promote the stemness and chemoresistance of colorectal cancer by transferring exosomal lncRNA H19\[J\]. Theranostics, 2018, 8(14): 3932-3948.
[30]Liang ZX, Liu HS, Wang FW, et al. LncRNA RPPH1 promotes colorectal cancer metastasis by interacting with TUBB3 and by promoting exosomesmediated macrophage M2 polarization\[J\]. Cell Death Dis, 2019, 10(11): 829.
[31]Soundararajan R, Paranjape AN, Maity S, et al. EMT, stemness and tumor plasticity in aggressive variant neuroendocrine prostate cancers\[J\]. Biochim Biophys Acta Rev Cancer, 2018, 1870(2): 229-238.
[32]Rajayi H, Tavasolian P, Rezalotfi A, et al. Cancer stem cells targeting; the lessons from the interaction of the immune system, the cancer stem cells and the tumor niche\[J\]. Int Rev Immunol, 2019, 38(1): 267-283.
[33]Rosenberger L, Ezquer M, LilloVera F, et al. Stem cell exosomes inhibit angiogenesis and tumor growth of oral squamous cell carcinoma\[J\].Sci Rep, 2019, 9 (1): 663.
[34]Yang L, Zhang Y. Tumorassociated macrophages:from basic research to clinical application\[J\]. J Hematol Oncol, 2017, 10 (1): 58.
[35]Vinay DS, Ryan EP, Pawelec G, et al. Immune ivasion in cancer: mechanistic basis and therapeutic strategies\[J\].Semin Cancer Biol, 2015, 35(Suppl): S185-S198.
[36]Dong L, Lin W, Qi P, et al. Circulating long RNAs in serum extracellular vesicles: their characterization and potential application as biomarkers for the diagnosis of colorectal cancer\[J\]. Cancer Epidemiol Biomarkers Prev, 2016, 25(7): 1158-1166.
[37]Liu T, Zhang X, Gao S, et al. Exosomal long noncoding RNA CRNDEh as a novel serumbased biomarker for diagnosis and prognosis of colorectal cancer\[J\]. Oncotarget, 2016, 7 (51): 85551-85563.
[38]Zhang C, Yang X, Qi Q, et al. LncRNAHEIH in serum and exosomes as a potential biomarker in the HCVrelated hepatocellular carcinoma\[J\]. Cancer Biomark, 2018, 21(3): 651.
[39]Xu H, Chen Y, Dong X, et al. Serum exosomal long noncoding RNAs ENSG00000258332.1 and LINC00635 for the diagnosis and prognosis of hepatocellular carcinoma\[J\]. Cancer Epidemiol Biomarkers Prev, 2017, 27 (6): 710-716.
[40]Zhao R, Zhang YL, Zhang X, et al. Exosomal long noncoding RNA HOTTIP as potential novel diagnostic and prognostic biomarker test for gastric cancer\[J\]. Mol Cancer, 2018, 17(1): 68.
[41]Lin LY, Yang L, Zeng Q, et al. Tumororiginated exosomal lncUEGC1 as a circulating biomarker for earlystage gastric cancer\[J\]. Mol Cancer, 2018, 17(1): 84.
[42]Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018\[J\].CA Cancer J Clin, 2018, 68(1):7-30.
|